Positive Health Online
Your Country
![[Image: http://www.abundanceandhealth.co.uk]](/img/original/BannerAvatar/2836.df7d2315253110ff5b3a566f94871f99.jpg "http://www.abundanceandhealth.co.uk")
![[Image: http://www.balens.co.uk]](/img/original/BannerAvatar/2148.50367fa908013fae0a7f1a171543ef92.jpg "http://www.balens.co.uk")
![[Image: https://www.water-for-health.co.uk/]](/img/original/BannerAvatar/4046.12831f50177f8848ee87b8e94411d6b3.jpg "https://www.water-for-health.co.uk/")
![[Image: http://www.drsgoodman.com/books-goodman/52-nutrition-and-cancer]](/img/original/BannerAvatar/1859.1296090fd8385e7ceff51c8011559097.jpg "http://www.drsgoodman.com/books-goodman/52-nutrition-and-cancer")
Research: LEACH and colleagues,
Listed in Issue 93
Abstract
LEACH and colleagues, Department of Cellular and Structural Biology, University of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78229, USA, review (71 references) the chemoprevention of prostate cancer with a focus on key opportunities and clinical trials. The list of potential agents for prostate cancer prevention continues to grow. It includes COX-2 inhibitors, vitamin D, soy, isoflavonoids, low-fat diet, and many others. As prospective trials are completed and the correlations with molecular genetics are developed, it seems certain that specific recommendations, tailored to individual patients, will emerge. Ultimately it can be foreseen that the main focus of prostate cancer control with shift from early detection and treatment to prevention.
Background
Methodology
Results
Conclusion
References
Leach R, Pollock B, Basler J, Troyer D, Naylor S, Thompson IM. Chemoprevention of prostate cancer. Focus on key opportunities and clinical trials. The Urologic Clinics of North America 30 (2): 227-237, May 2003.
